Kratom Dependence and Treatment Options: A Comprehensive Review of the Literature.

Current Drug Targets
Mohammad Farris Iman Leong Bin Abdullah

Abstract

Kratom, or Mitragyna speciosa Korth., is a tropical plant prevalent in Southeast Asia, and it is utilized as a traditional remedy for symptomatic relief of various illnesses. It has been labeled as an atypical opioid with significant narcotic-like properties, capable of inducing kratom dependence among those who misuse or abuse it. The prevalence of kratom use has drastically increased worldwide, raising concerns among healthcare providers, particularly regarding the availability of efficacious treatment options for kratom dependence. This manuscript provides a comprehensive narrative review of literature focusing on the psychoactive alkaloids of kratom, the possible neurobiological and pathophysiological models underlying the occurrence of kratom dependence, and the clinical presentations and effective treatment options available for kratom dependence. The psychoactive alkaloids of kratom, such as mitragynine (MG) and 7-hydroxymitragynine (7-HMG), act as partial mu opioid agonists and induce kratom dependence. As a result, regular kratom use leads to withdrawal symptoms on abstinence, along with craving, tolerance, and cross-tolerance to morphine. The psychological withdrawal symptoms reported include depressed mood, anxiety, ...Continue Reading

References

Jan 1, 1985·Journal of Substance Abuse Treatment·H D Kleber
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·P Y LawH H Loh
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·S AkhondzadehZ M Farzanehgan
Apr 5, 2001·Journal of Clinical Pharmacy and Therapeutics·S A Ahmadi-AbhariA Kamlipour
Dec 24, 2002·Journal of Substance Abuse Treatment·Evgeny KrupitskyAlexander Grinenko
Aug 12, 2004·Chemical & Pharmaceutical Bulletin·Hiromitsu Takayama
Mar 21, 2006·Life Sciences·Andrew C GrayPaul J White
Jul 14, 2006·Drug and Alcohol Dependence·Sawitri AssanangkornchaiAnocha Mukthong
May 26, 2007·Journal of Psychoactive Drugs·Evgeny M KrupitskyAlexander Y Grinenko
Dec 22, 2007·Substance Use & Misuse·Sawitri AssanangkornchaiUriwan Pattanasattayawong
May 17, 2008·Addiction·Edward W BoyerJohn H Halpern
Nov 21, 2009·Clinical Psychology Review·Jennifer C VeilleuxAdrienne J Heinz
Nov 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanhua RenYasmin L Hurd
Jan 30, 2010·International Journal of Molecular Sciences·Rocío González-LamotheKamal Bouarab
Mar 24, 2010·Journal of Substance Abuse Treatment·Walter LingBetty Tai
Apr 2, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zhi Zhang, Zhizhong Z Pan
Aug 28, 2010·European Addiction Research·Laura McWhirter, Siobhan Morris
Nov 6, 2010·Current Topics in Medicinal Chemistry·Jessica E AdkinsChristopher R McCurdy
Nov 30, 2010·Forensic Science International : Synergy·Torsten ArndtGerald Wolf
Feb 18, 2011·The Cochrane Database of Systematic Reviews·Silvia MinozziAnnette Verster
Apr 30, 2011·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Friedrich G KappMaren Hermanns-Clausen
Jun 30, 2011·Current Drug Abuse Reviews·Jolanta B Zawilska
Aug 6, 2011·Journal of Addiction Medicine·Sergey V Sheleg, Gregory B Collins
Jul 28, 2012·Journal of Forensic Sciences·Barry K LoganFrancis X Diamond
Dec 5, 2012·Neuroscience and Biobehavioral Reviews·Zurina HassanChristian P Müller
Jun 19, 2013·European Addiction Research·Roberta AgabioGian Luigi Gessa
Dec 3, 2013·Handbook of Experimental Pharmacology·Kirsten M Raehal, Laura M Bohn
Apr 5, 2014·Drug and Alcohol Dependence·Darshan SinghBalasingam K Vicknasingam
May 24, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Darika SaingamSanguan Lerkiatbundit
Jan 8, 2015·Frontiers in Pharmacology·Stéphane AlloucheNicolas Marie
May 8, 2015·Journal of Psychoactive Drugs·Darshan SinghSharif M Mansor
Aug 14, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yasmin L HurdDidier Jutras-Aswad
Oct 20, 2015·Expert Review of Clinical Pharmacology·Wojciech Leppert, Jarosław Woroń
Oct 30, 2015·International Journal of Legal Medicine·Marcus L WarnerOliver Grundmann
Nov 10, 2015·Peptides·Richard J Bodnar
Mar 26, 2016·Journal of Psychoactive Drugs·Darika SaingamSanguan Lerkiatbundit
Apr 20, 2016·International Journal of Molecular Sciences·Flaminia PantanoEnrico Marinelli

❮ Previous
Next ❯

Citations

Apr 20, 2021·Frontiers in Psychiatry·Alessandro E VentoGeorgios D Kotzalidis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Mark Sanderson, Adrianna Rowe
The International Journal on Drug Policy
Walter C ProzialeckDarshan Singh
Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse
Mohammad Farris Iman Leong Bin AbdullahDarshan Singh
© 2021 Meta ULC. All rights reserved